Search results for "illness"

showing 10 items of 1529 documents

Occurrence of a case of influenza A(H1N1)pdm09 and B co-infection during the epidemic season 2012–2013

2013

Abstract We report the detection of one case of co-infection with influenza A(H1N1)pdm09 and B, occurred during the 2012–2013 influenza season in Sicily. The dual infection was identified in a 18-year-old boy, who was not covered by specific vaccination and who had no other pre-existing risk factors. He presented classical symptoms of influenza-like illness developing no respiratory complications. A(H1N1)pdm09 viral concentration was initially about 10-fold higher than B virus, whereas its clearance was more rapidly achieved than in the case of B virus infection. Although influenza co-infection appears to be a rare event, a continued influenza surveillance activity is recommended, in order …

Microbiology (medical)Malemedicine.medical_specialtyRespiratory complicationsAdolescentMolecular Sequence DataBiologyInfluenza BSettore MED/42 - Igiene Generale E ApplicataMicrobiologyVirusInfluenza A Virus H1N1 SubtypeInfluenza HumanGeneticsmedicineInfluenza-like illnessHumansMolecular BiologySicilyEcology Evolution Behavior and SystematicsEpidemic seasonCoinfectionCo-infection Influenza; A(H1N1)pdm09; Influenza B; Influenza-like illnessPublic healthvirus diseasesInfluenza aVirologyVaccinationInfluenza B virusCo-infection InfluenzaInfectious DiseasesA(H1N1)pdm09ImmunologyEpidemiological MonitoringHuman mortality from H5N1Co infection
researchProduct

Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY …

2021

Objectives: We aimed to develop and validate a prediction model, based on clinical history and examination findings on initial diagnosis of coronavirus disease 2019 (COVID-19), to identify patients at risk of critical outcomes. Methods: We used data from the SEMI-COVID-19 Registry, a cohort of consecutive patients hospitalized for COVID-19 from 132 centres in Spain (23rd March to 21st May 2020). For the development cohort, tertiary referral hospitals were selected, while the validation cohort included smaller hospitals. The primary outcome was a composite of in-hospital death, mechanical ventilation, or admission to intensive care unit. Clinical signs and symptoms, demographics, and medical…

Microbiology (medical)medicine.medical_specialtyEvidence-based medicinePrognostic modelsReferralMedicinaCritical IllnessLogistic regressionInitial assessmentRisk Assessmentlaw.inventionlawmedicineHumansMedical historyGeneralizability theoryHospital MortalityRetrospective Studiesbusiness.industryMedicina basada en l'evidènciaCOVID-19Easily obtained clinical variablesGeneral MedicineModels Theoreticalmedicine.diseaseIntensive care unitConfidence intervalHospitalizationInfectious DiseasesSpainEmergency medicineCohortCritical illnessbusinessKidney disease
researchProduct

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.

2006

Variation in major histocompatibility complex genes on chromosome 6p21.3, specifically the human leukocyte antigen HLA-DR2 or DRB1*1501-DQB1*0602 extended haplotype, confers risk for multiple sclerosis (MS). Previous studies of DRB1 variation and both MS susceptibility and phenotypic expression have lacked statistical power to detect modest genotypic influences, and have demonstrated conflicting results. Results derived from analyses of 1339 MS families indicate DRB1 variation influences MS susceptibility in a complex manner. DRB1*15 was strongly associated in families (P=7.8x10(-31)), and a dominant DRB1*15 dose effect was confirmed (OR=7.5, 95% CI=4.4-13.0, P<0.0001). A modest dose effect…

Models MolecularMaleSequence Homologyimmune system diseasesModelsRisk FactorsDatabases GeneticAdult Alleles Amino Acid Sequence Databases; Genetic Female Genetic Variation Genotype HLA-DR Antigens; chemistry/genetics HLA-DRB1 Chains Humans Male Middle Aged Models; Molecular Molecular Sequence Data Multiple Sclerosis; Chronic Progressive; genetics/immunology Multiple Sclerosis; genetics/immunology Phenotype Risk Factors Sequence Homology; Amino Acidskin and connective tissue diseasesHLA-DRB1Genetics (clinical)GeneticsGeneral MedicineMultiple Sclerosis Chronic ProgressiveMiddle AgedAmino AcidChronic ProgressivePhenotypeFemalemusculoskeletal diseasesAdultMultiple SclerosisGenotypeMolecular Sequence DataLocus (genetics)Human leukocyte antigenBiologyDatabases. Alleles phenotype heterogeneity human leukocyte antigens age of onset chromosomes genes genotype haplotypesmultiple sclerosis relapsing-remitting genetics disability primary progressive multiple sclerosis hla-drb1 gene illness length severity of illnessGeneticGenetic variationGeneticsmedicineHumansAmino Acid SequenceAlleleMolecular BiologyAllelesSequence Homology Amino AcidMultiple sclerosisHaplotypeGenetic VariationMolecularHLA-DR Antigensmedicine.diseasegenetics/immunologychemistry/geneticsImmunologyAge of onsetHLA-DRB1 Chains
researchProduct

Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study

2020

Background: Cyclosporine A (CsA) is one of the systemic therapeutic options for moderate-to-severe psoriasis, based on its efficacy and rapidity of action. The current study investigated the response to CsA in patients with moderate-to-severe plaque psoriasis. Materials and Methods: TRANSITION was an observational, cross-sectional, multicentre study which evaluated the proportion of partial- and suboptimal-responders among patients with moderate-to-severe plaque psoriasis treated with continuous CsA for &gt;= 12 weeks. Patients demonstrating a Psoriasis Area and Severity Index (PASI) response of &gt;= 90, &gt;= 75 and &lt;90, &gt;= 50 and &lt;75 and &lt;50 were defined as responders, subopt…

Moderate to severeMalemedicine.medical_specialtysystemic therapy.macromolecular substancesDermatologySystemic therapySeverity of Illness Indexsystemic therapy030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePsoriasisMedicineHumansPsoriasisIn patientPASI; cyclosporine A; moderate to severe plaque psoriasis; systemic therapy030203 arthritis & rheumatologyPlaque psoriasisbusiness.industryPASIMiddle Agedmedicine.diseasemoderate to severe plaque psoriasiDermatologycyclosporine A; moderate to severe plaque psoriasis; PASI; systemic therapyCross-Sectional StudiesTreatment OutcomeCyclosporineQuality of LifeFemalebusinesscyclosporine Amoderate to severe plaque psoriasis
researchProduct

Severe third molar complications including death-lessons from 100 cases requiring hospitalization.

2006

Purpose In this study we investigated patients that were hospitalized due to third molar (M3) complications. Specifically we analyzed frequency, age distribution, and outcome with respect to the M3 clinical status. Patients and Methods We set up a prospective cohort study and included 100 subjects admitted for management of acute M3-associated complications. The clinical status of the M3 was defined as 1 ) prophylactic M3 removal, 2 ) therapeutic (nonelective) M3 removal, or 3 ) M3 present at the time of admission. Outcome variables were clinical infection markers (C-reactive protein, leukocyte counts) and economic parameters (treatment costs, length of hospital stay, and days of disability…

MolarAdultMalemedicine.medical_specialtyPericoronitisAdolescentMyocardial InfarctionLeukocyte CountsStatistics NonparametricLeukocyte CountFatal OutcomeCost of IllnessGermanySickness Impact ProfilemedicineHumansSurgical Wound InfectionMyocardial infarctionProspective StudiesHospital CostsProspective cohort studyAgedAged 80 and overbusiness.industryLength of StayMiddle Agedmedicine.diseaseProphylactic SurgerySurgeryC-Reactive ProteinOtorhinolaryngologyTooth ExtractionSurgeryObservational studyFemaleMolar ThirdPericoronitisOral SurgeryComplicationbusinessJournal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
researchProduct

Periodontal disease affecting tooth furcations. A review of the treatments available

2007

The molars are the teeth that suffer the greatest periodontal destruction in untreated patients. When periodontal disease affects the furcation of a tooth, the chance that it will be lost increases considerably. An increase in the exposed root surface, anatomical peculiarities and irregularities of the furcation surface all favor the growth of bacteria. These problems make it harder for the patient to maintain hygiene, and impede adequate treatment. The treatment of furcations affected by periodontal disease is one of the most difficult problems for the general dentist and periodontist. The motivation of both the attending professional and of the patient are therefore of great importance. N…

MolarOrthodonticsRoot surfacePeriodontistbusiness.industryFurcation DefectsDentistryGeneral dentist:CIENCIAS MÉDICAS [UNESCO]Severity of Illness IndexOtorhinolaryngologyPeriodontal diseaseUNESCO::CIENCIAS MÉDICASHumansMedicineSurgerybusinessGeneral DentistryMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Virginia Woolf : between writing and disease

2018

The authors offer an analysis of mental illness in the work of a key twentieth century author: Virginia Woolf. A critical review of her literary legacy allows us to get closer to what might be one of the most intense literary portrayals of illness and its metaphors and, at the same time, to the representations, euphemisms, silences, and monsters depicted in the chapters of her life and in the unique voice of an essential author.

MultidisciplinaryPsychoanalysisHistoryHistory and Philosophy of SciencemedicineDiseaseMental illnessmedicine.diseaseKey (music)
researchProduct

Neuronal injury in chronic CNS inflammation.

2010

Introduction Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Neurological symptoms include sensory disturbances, optic neuritis, limb weakness, ataxia, bladder dysfunction, cognitive deficits and fatigue. Pathophysiology The inflammation process with MS is promoted by several inflammatory cytokines produced by the immune cells themselves and local resident cells like activated microglia. Consecutive damaging pathways involve the transmigration of activated B lymphocytes and plasma cells, which synthesize antibodies against the myelin sheath, boost the immune atta…

Multiple SclerosisInflammationNeuroprotectionSeverity of Illness IndexProinflammatory cytokineCentral Nervous System DiseasesmedicineAnimalsHumansRemyelinationNeuroinflammationInflammationNeuronsMicrogliabusiness.industryMultiple sclerosismedicine.diseaseAstrogliosisAnesthesiology and Pain Medicinemedicine.anatomical_structureNeuroprotective AgentsImmunologyChronic DiseaseMicrogliamedicine.symptomInflammation MediatorsbusinessBest practiceresearch. Clinical anaesthesiology
researchProduct

Accuracy of SCORTEN to predict the prognosis of Stevens‐Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta‐analysis

2019

BACKGROUND The SCORTEN score is a specific predictor of the probability of death for patients diagnosed with Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). OBJECTIVES To evaluate the overall accuracy of SCORTEN and the influence of several moderators such as age, sex, geographical region and age of the study. METHODS A systematic search was performed on MEDLINE, The Cochrane Library, EMBASE, SCOPUS and Web of Knowledge, with no restriction on language (last update 5 February 2019 for all databases). Original studies on the use of SCORTEN were eligible. The standardized mortality ratio (SMR), defined as the quotient between the number of deaths observed and the number expec…

Multivariate statisticsmedicine.medical_specialtyBody Surface AreaMEDLINEDermatologyDiseaseCochrane LibrarySeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansRetrospective StudiesBody surface areabusiness.industry030208 emergency & critical care medicinePrognosismedicine.diseaseToxic epidermal necrolysisInfectious DiseasesStandardized mortality ratioStevens-Johnson SyndromeMeta-analysisbusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

The Relapsing Polychondritis Disease Activity Index: Development of a disease activity score for relapsing polychondritis.

2012

Abstract Objective The rarity of relapsing polychondritis (RP) has hindered the development of standardized tools for clinical assessment. Here, we describe the development of a preliminary score for disease assessing activity in RP, the Relapsing Polychondritis Disease Activity Index (RPDAI). Methods Twenty-seven RP experts participated in an international collaboration. Selection and definition of items for disease activity were established by consensus during a 4-round internet-based Delphi survey. Twenty-six experts assessed the Physician's Global Assessment (PGA) of disease activity on 43 test cases on a 0–100 scale, yielding a total of 1118 PGA ratings. The weight of each item was est…

Multivariate statisticsmedicine.medical_specialtybusiness.industryImmunologyDelphi methodDiseasemedicine.diseaseSeverity of Illness IndexGeeInternal medicineSeverity of illnessPhysical therapyImmunology and AllergyMedicineHumansPolychondritis RelapsingbusinessGeneralized estimating equationRelapsing polychondritisRare disease
researchProduct